Cargando…
Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
Renal clear cell carcinoma (ccRCC) comprises over 75% of all renal tumors and arises in the epithelial cells of the proximal convoluted tubule. Molecularly ccRCC is characterized by copy number alterations (CNAs) such as the loss of chromosome 3p and VHL inactivation. Additional driver mutations (SE...
Autores principales: | Weaver, Chaston, Bin Satter, Khaled, Richardson, Katherine P., Tran, Lynn K. H., Tran, Paul M. H., Purohit, Sharad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687861/ https://www.ncbi.nlm.nih.gov/pubmed/36428521 http://dx.doi.org/10.3390/biomedicines10112953 |
Ejemplares similares
-
Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics
por: Bin Satter, Khaled, et al.
Publicado: (2022) -
Oncocytoma-Related Gene Signature to Differentiate Chromophobe Renal Cancer and Oncocytoma Using Machine Learning
por: Satter, Khaled Bin, et al.
Publicado: (2022) -
The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Kang, Weiting, et al.
Publicado: (2020) -
Comparative analysis of transcriptomic profile, histology, and IDH mutation for classification of gliomas
por: Tran, Paul M. H., et al.
Publicado: (2020) -
Corrigendum to “The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma”
por: Kang, Weiting, et al.
Publicado: (2020)